Role of Selenof as a Gatekeeper of Secreted Disulfide-Rich Glycoproteins
Sun Hee Yim(Brigham and Women's Hospital), Vadim N. Gladyshev(Brigham and Women's Hospital), Robert A. Everley(Frontier Aerospace Corporation (United States)), Andrea Orsi(Vita-Salute San Raffaele University), Dmitry E. Fomenko(University of Nebraska–Lincoln), Arlene H. Sharpe(Brigham and Women's Hospital), Petra A. Tsuji(Towson University), Sang‐Goo Lee(Brigham and Women's Hospital), Kutay Karatepe(Boston Children's Hospital), Frank A. Schildberg(University Hospital Bonn), Roberto Sitia(Vita-Salute San Raffaele University), Steven P. Gygi(Harvard University), Hongbo R. Luo(Hangzhou Medical College), Zachary R. Barbati(Harvard University), Dolph L. Hatfield(Northwestern University)
Cited by 63
Related Papers
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
|The Journal of Experimental Medicine|2009|2k
A quantitative atlas of mitotic phosphorylation
|Proceedings of the National Academy of Sciences|2008|1.6k
Selenoproteins: Molecular Pathways and Physiological Roles
|Physiological Reviews|2014|1.4k